Error: Could not add to watchlist. X
+ Watchlist

Carnegie Fund II - Biotechnology Sub-Fund

CARBIOA:LX
30.76
EUR
As of 12:00 AM EDT 9/22/2017
Fund Type
SICAV
52Wk Range
23.36 - 32.47
1 Yr Return
6.00%
YTD Return
12.96%
Before it's here, it's on the Bloomberg Terminal.
Learn More
52Wk Range
23.36 - 32.47
1 Yr Return
8.23%
YTD Return
12.96%
Fund Type
SICAV
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
International
NAV (on 09/22/2017)
30.76
Total Assets (m EUR) (on 11/30/2016)
27.608
Inception Date
10/10/2000
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
ULF ARVIDSSON
Front Load Fee
-
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.10%
Expense Ratio
1.10%

Top Fund Holdings

Name Position Value % of Fund
8.60 k 992.93 k 9.04
12.21 k 792.21 k 7.21
3.20 k 789.83 k 7.19
6.00 k 784.15 k 7.14
5.30 k 611.67 k 5.57
5.35 k 401.63 k 3.66
3.30 k 387.12 k 3.53
2.50 k 332.79 k 3.03
4.35 k 332.66 k 3.03
5.24 k 290.68 k 2.65
Profile
C WorldWide Biotechnology is an open-end investment fund registered in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests in equities of companies in the biotechnology/bioscience area including companies with activities in the areas of drug discovery & delivery, therapeutics, and enabling technologies with market cap less than 500 million.
Address
Carnegie Fonder
Box 7828
103 97 Stockholm
Sweden
Phone
46-08-12-15-50-00 Tel